Gut hormone GLP-1 / weight and blood sugar
Tirzepatide led an older weekly shot in two direct studies.
In SURPASS-2, every dose lowered the blood sugar average more than semaglutide, an older weekly shot. SURMOUNT-5 found -20.2% weight loss with Tirzepatide and -13.7% with that shot.
Appetite may quiet before the scale moves
Your appetite may quiet first, with the scale moving later. Tirzepatide is an FDA-approved weekly shot for type 2 diabetes (2022), obesity (2023), and sleep apnea caused by blocked breathing (2024), but those approvals don't show whether tirzepatide suits your own case.
After food, your bowel sends out two hormones: GIP and GLP-1, which help prompt your pancreas to move insulin into your blood. Older shots copy GLP-1 alone, while tirzepatide copies both GIP and GLP-1.
Your doctor still needs your health record before deciding whether the shot fits you. In SURMOUNT-1, 2,539 people took part for 72 weeks.
The group on the highest dose lost an average 20.9% of body weight [4]. SURMOUNT-5 tested adults without diabetes and found -20.2% with tirzepatide, against -13.7% with an older weekly shot [5].
Nausea, constipation, and diarrhea showed up most during the dose rise. The effects page separates study findings from what users say they felt.
Tirzepatide lowered weight and the blood sugar average
What caught me off guard was the size of the lead in two direct studies. Both drugs were tested in people facing the same study rules.
Tirzepatide is a 39-amino-acid chain, meaning linked pieces used to build proteins. An added part makes the body take about a 5-day span to remove half [1].
GIP and GLP-1 are two gut hormones released once food arrives. GLP-1 helps hold food in your stomach, while the other message also affects insulin and hunger.
In cells kept alive in a dish, tirzepatide copied one message more strongly than GLP-1. The dish doesn't tell how strongly that lab result matters inside your body [2].
Adults with type 2 diabetes took part across five large SURPASS studies. In SURPASS-1, both weight and the blood sugar average fell farther as the dose rose [8].
SURPASS-2 put tirzepatide beside semaglutide, an older weekly shot, in 1,879 people for 40 weeks. At 5 mg the blood sugar average fell 2.01 points, at 10 mg it fell 2.24, and at 15 mg it fell 2.30.
Semaglutide 1 mg lowered that average by 1.86 points [3]. Tirzepatide also led on weight by 1.9 kg, 3.6 kg, and 5.5 kg as its dose rose [3].
SURMOUNT studied adults whose records showed no diabetes. SURMOUNT-1 followed 2,539 people for 72 weeks.
Weight changed by -15.0%, -19.5%, and -20.9% on 5, 10, and 15 mg, against -3.1% with an inactive shot [4]. SURMOUNT-5 followed 751 adults and found -20.2% with tirzepatide against -13.7% with semaglutide [5].
Later work asked about heart failure, stopped breathing during sleep, and a serious liver illness caused by built-up fat. Those studies answer different questions.
Tirzepatide vs semaglutide: Tirzepatide led both studies
Semaglutide is an older weekly medicine built around one hormone from the gut. Two direct studies compared it with tirzepatide, though the patients and doses differed.
SURPASS-2 followed 1,879 people with type 2 diabetes for 40 weeks. The paper prints the tirzepatide doses as 5/10/15 mg, from low to high. Every dose lowered the blood sugar average more than semaglutide 1 mg [3].
At each of the three doses, tirzepatide also led on weight. The paper's compact numbers are left to the source so you don't have to match three doses to three results here.
SURMOUNT-5 followed 751 adults who had obesity without type 2 diabetes for 72 weeks. Each person worked toward an amount they could tolerate: tirzepatide at 10 or 15 mg, or semaglutide at 1.7 or 2.4 mg.
The tirzepatide group averaged -20.2%, while the semaglutide group averaged -13.7%. The paper prints its four weight goals as 10/15/20/25%; those are separate marks from smallest to largest [5].
The dose gap can't be ignored when you weigh these results. SURPASS-2 used semaglutide 1 mg, while SURMOUNT-5 used the highest amount each person could tolerate.
Tirzepatide brought large weight loss in two studies
SURMOUNT-1 recorded a large weight drop compared with placebo, an inactive shot. At 15 mg, 63% of people lost at least 20% of body weight in 72 weeks, against 1.3% with placebo [4].
The study included adults whose body mass index, a height-to-weight measure, was 30 or higher. It also included people at 27 or higher who had a weight-linked illness, but no type 2 diabetes.
SURMOUNT-5 put tirzepatide beside semaglutide and found -20.2% against -13.7% [5]. During a 20-week stretch, the dose rose and then stayed at the set level.
SURPASS-2 also checked weight, though blood sugar was its main question. At the highest dose, tirzepatide led semaglutide 1 mg by 5.5 kg [3].
A later SURMOUNT-1 review split the lost weight into fat and everything else. About 25% was muscle, bone, water, and other non-fat tissue; about 75% was fat [12].
Tirzepatide reviews mix study results with personal reports
Across the SURPASS and SURMOUNT studies, tirzepatide lowered the blood sugar average and body weight [7]. A medical guide also explains its two gut-hormone effects and sums up those results [7].
Researchers later asked patients what changed in daily life. In those talks, 79-91% named less hunger, 62-79% named more energy, and 47-55% named a lift in mood or confidence.
Those are the patients' own reports, not changes proved by a controlled test. Tirzepatide effects keeps those accounts apart from the trial findings.
The main studies didn't all follow the same people. Even so, SURPASS-1 through -5 and SURMOUNT-1 and -5 found lower weight or blood sugar at 5, 10, and 15 mg.
The Tirzepatide peptide is made in a lab
Tirzepatide is a 39-amino-acid chain, meaning linked pieces used to build proteins. Its shape lets it copy messages from a pair of hormones made by your gut once a meal arrives.
One of those hormones is GLP-1, which helps slow your stomach and make hunger less sharp. Chemists also added a small fat molecule that lets the medicine ride on albumin, a protein carried through your blood.
The body then takes about a 5-day span to remove half, which makes a weekly shot possible [1]. After food, the two gut hormones also prompt your pancreas to move insulin into your blood.
The effect eases as sugar falls, so low blood sugar is less likely when no other diabetes drug is used [7]. The tirzepatide injection page shows the three shot areas and explains why the dose rises slowly.
Tirzepatide cost depends on your coverage
A licensed pharmacy fills tirzepatide only after a prescription. Your cost can't be known from the list price alone because it can also depend on insurance, which drugs your plan covers, maker help, and where you live at the time.
The maker's list price can change, and it may not match what you pay. You won't find a live price or a seller on these pages.
No link here leads to a store, pharmacy, or custom-mixing service. Your clinic and insurance plan can tell you the cost in your case.